Publications

5600 Results

Cooperative group trials in the community setting

Authors
JL Wade;NJ Petrelli;W McCaskill-Stevens
Journal / Conference
Seminars in Oncology, Oct;42(5):686-692;
Year
2015
Research Committee(s)
Cancer Care Delivery
PMID
PMID26433550
PMC
PMC4692715

Genetic testing and tissue banking for personalized oncology: analytical and institutional factors

Authors
G Miles;J Rae;S Ramalingam;J Pfeifer
Journal / Conference
Seminars in Oncology, Oct;42(5):713-723;
Year
2015
Research Committee(s)
Multiple sites
PMID
PMID26433552
PMC
PMC4705034

Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance)

Authors
K Ng;AP Venook;K Sato;BW Hollis;D Niedzwiecki;C Ye;I-W Chang;BH O'Neil;F Innocenti;H-J Lenz;CD Blanke;CS Fuchs;JA Meyerhardt
Journal / Conference
Journal of Clinical Oncology 33(suppl 3; abstr 507); poster; ASCO Gastrointestinal Cancers Sympos (Jan 15-17, 2015, San Francisco, CA);
Year
2015
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Ongoing use of data and specimens from NCI-sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program (CCOP)

Authors
L Minasian;C Tangen;DL Wickerham
Journal / Conference
Seminars in Oncology, Oct;42(5):748-763
Year
2015
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID26433556
PMC
PMC4593316
Study Number(s)
S0000, SWOG-9217

Involving the patient/advocate in publicly-funded cancer research

Authors
J Perlmutter;N Roach;ML Smith
Journal / Conference
Seminars in Oncology, Oct;42(5):681-685;
Year
2015
Research Committee(s)
Cancer Care Delivery
PMID
PMID26433549

Social media and oncology: the past, present, and future of electronic communication between physician and patient

Authors
MA Lewis;AP Dicker
Journal / Conference
Seminars in Oncology, Oct;42(5):764-771;
Year
2015
Research Committee(s)
Cancer Care Delivery
PMID
PMID26433557
PMC
PMC4699327

Phase I safety data of lenalidomide, bortezomib, dexamethasone, and eloutuzmab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211

Authors
S Usmani;R Sexton;S Ailawadhi;JJ Shah;J Valent;MA Rosenzweig;B Lipe;JA Zonder;S Fredette;B Durie;A Hoering;B Bartlett;R Orlowski
Journal / Conference
Blood Cancer Journal Aug 7;5:e334
Year
2015
Research Committee(s)
Myeloma
PMID
PMID26252787
PMC
PMC4558587
Study Number(s)
S1211

Chemohormonal therapy in metastatic hormone- sensitive prostate cancer

Authors
C Sweeney;Y-H Chen;M Carducci;G Yiu;D Jarrard;WN Wong;MA Eisenberger;N Hahn;M Kohli;MM Cooney;R Dreicer;N Vogelzang;J Picus;D Shevrin;M Hussain;J Garcia;R DiPaola
Journal / Conference
New England Journal of Medicine, Aug 20;373(8):737-746
Year
2015
Research Committee(s)
Genitourinary
PMID
PMID26244877
PMC
PMC4562797
Study Number(s)
CTSU/E3805

The master protocol concept

Authors
M Redman;C Allegra
Journal / Conference
Seminars in Oncology, Oct;42(5):724-730
Year
2015
Research Committee(s)
Lung
PMID
PMID26433553
PMC
PMC4681517
Study Number(s)
S1400

Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405

Authors
V Heinemann;D Niedzwiecki;R Pearline;H Lenz;F Innocenti;H Hochster;A Grothey;RM Goldberg;RJ Mayer;RL Schilsky;M Bertagnolli;C Blanke;A Venook;S Stinzing;BH O'Neil
Journal / Conference
Journal of Clinical Oncology 33:5s (suppl; abstr 3585); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
Year
2015
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405